+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05974475

MONDRIAN Study on Early-stage Non-small Cell Lung Cancer Combining Clinical and Molecular Data to Predict Response to Stereotactic Body Radiotherapy or Surgery

Led by European Institute of Oncology · Updated on 2024-09-23

270

Participants Needed

2

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating early-stage non-small cell lung cancer NSCLC, focusing on why some patients respond well to Stereotactic Body Radiotherapy SBRT while others do not. This observational study aims to identify clinical, imaging, and biological factors that may predict how patients will respond to SBRT. The study compares patients treated with SBRT to those treated with surgery to understand which factors indicate disease behavior and treatment response. Participants will receive either SBRT or surgery based on the best clinical practices. SBRT is a high-precision radiation treatment delivered in 3-5 sessions, with doses tailored to patient and tumor characteristics like lung health and tumor location. Surgery involves pulmonary anatomical resection and lymph node removal. Both treatment groups will contribute data for advanced analyses, including imaging, gene expression, and proteomics, to build predictive models. During the 60-month study, participants will have routine clinical data collected, including scans CT and PET, blood tests, and tissue analysis from tumors or biopsies. Researchers will use this information to develop complex models predicting disease progression and treatment outcomes. The main outcome measured is progression-free survival over 24 months. The study also applies advanced techniques like deep neural networks and federated learning to integrate data from multiple sources and reduce bias.

CONDITIONS

Brief Title

MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer

Research Team

S

Stefania Volpe, MD, PhD

C

Cristiana Fodor, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here